Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

FDA authorizes protein-based Novavax Covid vaccine for adults

Approval of shot widens options against the virus as CDC will meet next week to decide whether to sign off on vaccine

The Guardian - US

These Brazilian besties are inventing an mRNA vaccine as a gift to the world

Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it.

WEKU

US regulators OK new COVID-19 shot option from Novavax

The U.S. is getting another COVID-19 vaccine choice

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Novavax Covid vaccine becomes fourth to receive FDA approval

The protein-based vaccine still needs to be approved by the CDC before it can start to be administered

The Independent UK

FDA authorizes Novavax COVID vaccine for emergency use

"Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19."

Axios

We lost the plot on COVID messaging – now governments will have to be bold to get us back on track

Overall, Australian governments managed the first two years of the COVID pandemic well. Border closures and state actions such as lockdowns averted 18,000 deaths in 2020 and 2021.

The Conversation

We lost the plot on COVID messaging – now governments must be bold to get us back on track

We are in the grip of a fresh COVID wave, but governments are more reluctant to introduce measures to curb its spread. How did it come to this?

The New Daily

Read news from The Economist, FT, and more,
with one subscription

Covid vaccine: Government to give free boosters from tomorrow for 75 days

NEW DELHI: With an aim to boost uptake, the Centre has decided to give free booster shots of the Covid vaccine to all in the 18-59 age group at government vaccination centres. This will be facilitated under a 75-day special drive from July 15 as part of the government's Azadi…

The Times of India

Should you book in your second COVID-19 booster? Here's how Israel's fourth dose changed the fight against Omicron

For Australians over 30, a fourth COVID-19 vaccine jab is now available. In Israel, the first country in the world to embrace the second booster, the benefits for some people were dramatic.

ABC News

The Sputnik V conundrum

Why the Supreme Court could have heard the plea seeking modification of the Indian government’s COVID-19 policy

The Hindu

NYC monkeypox site crashes as city struggles to keep up with demand for vaccines

‘We apologise for the frustration caused and are working to build stable appointment infrastructure,’ the city health department said

The Independent UK

Monkeypox cases in Georgia increase to 48

ATLANTA — With the number of monkeypox cases ticking upward in Georgia and around the world, more monkeypox vaccines are expected to arrive in the state soon as part of a nationwide effort to stem the outbreak.

Tribune News Service

White House is teaming up with LGBT+ advocacy group GLAAD for a monkeypox briefing

Comes as many are concerned about the monkeypox vaccine and also stigmatisation

The Independent UK

What is the Amazon cancer vaccine trial?

The trial will study the safety of personalised vaccines to treat patients with skin and breast cancer.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Liverpool Echo

Experts warn Monkeypox could become endemic if urgent action not taken

A group of sexual health experts are calling for £51m from the Department of Health and Social Care to “control the outbreak"

Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google's Hiring Slowdown, Panasonic's New EV Battery And Other Top Financial Stories Wednesday, July 13

CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge

Los Angeles Times

Will Americans have the right COVID-19 vaccine this fall? Maybe

In a few short months, the weather will turn crisp, the holiday season will draw near, and the coronavirus may embark on its third consecutive winter of death and devastation.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Three million people in England yet to get a Covid jab

MPs call for ‘redoubled’ efforts to jab unvaccinated people

The Hindu

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Centre recently reduced the gap between the second and precaution doses of COVID-19 vaccines from nine to six months

The Guardian - UK

Calls for return of Covid controls after UK death toll passes 200,000

‘Damning milestone’ means measures such as mask-wearing and better sick pay needed again, doctors and bereaved families say

The Independent UK

‘Stealthy’ new Covid variant can reinfect you every month

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

ABC News

What's the latest news on COVID-19? Here's a recap of the updates on vaccine booster shots, RATs and mask rules

The free RAT scheme is coming to an end, most jurisdictions have tweaked their rules around reinfection, and more people can get vaccine boosters. But it doesn't look like mask rules are changing.

Reuters

Why world's first malaria shot won't reach millions of children who need it

After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.

The Philadelphia Inquirer

Why BA.5 is not a super-virus, and how the vaccines are still the best option against COVID

The BA.5 “subvariant” of the coronavirus has rapidly become dominant in the United States, and rising COVID-19 case numbers are dashing hopes for a summer break from the pandemic.

1 … 228 229 230 231

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

889 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.